Steven Godin, PhD, DABT

Dr. Godin has over 30 years of experience in the CRO industry and pharmaceutical drug development, resulting in a diverse and unique combination of experience and leadership. Prior to joining Smithers Avanza Toxicology Services, he held scientific and leadership roles at Wright-Patterson Air Force Base, MPI Research, White Eagle Laboratories, and Cephalon. His areas of expertise include drug metabolism, biochemical toxicology, ocular and dermal toxicity, safety studies of oncology products, vaccine safety and biodistribution studies, reproductive toxicity studies in canines and felines, target animal safety studies of veterinary pharmaceuticals, juvenile toxicology studies, wound healing studies, and developing, implementing, and conducting novel testing protocols. He has also served as Principle Investigator on programs for the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute of Allergy and Infectious Diseases. He is experienced in providing preclinical advice on scientific issues in drug development, has participated pre-IND meetings with the FDA, and was a member of project teams which resulted in successful filing of INDs and NDAs for the FDA. He has over 100 publications and abstract presentations in scientific journals and at conferences.

Required fields *
*
*
*
Country *
*
*